|
DTX3L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.77969999998395E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.40799999951369E-07 |
| Normal-vs-Stage2 |
2.350400E-01 |
| Normal-vs-Stage3 |
6.833300E-04 |
| Normal-vs-Stage4 |
1.241010E-03 |
| Stage1-vs-Stage2 |
9.040700E-03 |
| Stage1-vs-Stage3 |
2.744400E-01 |
| Stage1-vs-Stage4 |
6.464000E-01 |
| Stage2-vs-Stage3 |
9.125800E-02 |
| Stage2-vs-Stage4 |
6.890200E-02 |
| Stage3-vs-Stage4 |
7.283200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.17619999995267E-06 |
| Normal-vs-AfricanAmerican |
5.516600E-03 |
| Normal-vs-Asian |
3.63380000000246E-05 |
| Caucasian-vs-AfricanAmerican |
7.487800E-01 |
| Caucasian-vs-Asian |
3.711800E-01 |
| AfricanAmerican-vs-Asian |
3.483200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.017400E-03 |
| Normal-vs-Female |
2.93200000001104E-06 |
| Male-vs-Female |
4.164200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.08940000143454E-08 |
| Normal-vs-Age(41-60Yrs) |
2.828900E-04 |
| Normal-vs-Age(61-80Yrs) |
4.332300E-02 |
| Normal-vs-Age(81-100Yrs) |
9.924000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.396000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.042100E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.162200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.592750E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.391550E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.272400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.551800E-01 |
| Classical-VS-Follicular |
2.55240273361323E-13 |
| Classical-VS-Other |
6.516500E-02 |
| Classical-VS-Normal |
5.99869998119118E-09 |
| Tall-VS-Follicular |
1.73130000002963E-07 |
| Tall-VS-Other |
2.511600E-02 |
| Tall-VS-Normal |
3.06610000000429E-06 |
| Follicular-VS-Other |
5.249600E-01 |
| Follicular-VS-Normal |
4.070000E-01 |
| Other-VS-Normal |
7.608000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.335500E-03 |
| Normal-vs-N1 |
3.431500E-04 |
| N0-vs-N1 |
1.352430E-01 |
|
|
